Boehringer al­lo­cates €120M to boost pro­duc­tion of Jar­diance in Greek plant

Boehringer In­gel­heim is un­der­go­ing a €120 mil­lion ex­pan­sion of its fa­cil­i­ty in Ko­ropi, Greece, to boost pro­duc­tion of its block­buster drug Jar­diance, among oth­er com­mer­cial and clin­i­cal as­sets.

The new ex­ten­sion will in­crease man­u­fac­tur­ing for its port­fo­lio in car­dio-re­nal-meta­bol­ic, men­tal health and pul­monary fi­bro­sis, Boehringer said in a Thurs­day re­lease. The ex­pan­sion will add 110 ad­di­tion­al jobs to the ex­ist­ing 700 em­ploy­ees.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER